12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Other News

Human Genome Sciences, Roche, City of Hope National Medical Center autoimmune news

Human Genome filed suit against Roche's Genentech Inc. unit and the City of Hope in the U.S. District Court of the District of Delaware challenging the validity of the Cabilly III patent (U.S. Patent No. 7,923,221) covering methods of antibody production. The biotech, which requested a trial by jury, is seeking declaratory judgment that the patent is invalid, unenforceable...

Read the full 282 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >